Shahram Shahabi

From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease

Alastair Brown, Sophie J. Bradley, Fiona H. Marshall et al. · Cell · 2021 · 87 citations · Full text

Molecular Pharmacology, Neurodegenerative Diseases, Alzheimer's Disease +10

Hot and Cold Natures and Some Parameters of Neuroendocrine and Immune Systems in Traditional Iranian Medicine: A Preliminary Study

Shahram Shahabi, Zuhair Muhammad Hassan, Mehdi Mahdavi et al. · The Journal of Alternative and Complementary Medicine · 2008 · 81 citations

Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophrenia

Gary Gilmour, Elsa Y. Pioli, Sophie Dix et al. · Psychopharmacology · 2009 · 78 citations

Psychiatry, Behavioral Neuroscience, Medicine +14

Association of altered gut microbiota composition with chronic urticaria

Edris Nabizadeh, Nima Hosseini Jazani, Morteza Bagheri et al. · Annals of Allergy Asthma & Immunology · 2017 · 61 citations

Microbiota Structure, Microbiota Function, Dysbiosis +6

A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine

Abbas Jamali, Mehdi Mahdavi, Zuhair M Hassan et al. · International Immunology · 2009 · 49 citations · Full text

Immunology, Immunotherapy, Synthetic Immunology +19